세계의 천골신경 자극기기 시장 규모는 2023년에 10억 6,405만 달러에 이르렀고, 2024년부터 2030년까지 예측기간에 CAGR 11.66%의 성장이 전망됩니다. 천골신경 자극기기 수요는 주로 요폐, 절박성 빈뇨, 변실금 등 증가에 의해 추진되고 있습니다. 게다가 혁신적인 선진기술의 채용 증가, 저침습 치료 접근법에 대한 수요 증가, 제품 출시 및 승인 증가 등이 2024년부터 2030년까지 예측 기간의 천골신경 자극기기 시장의 전반적인 성장에 기여합니다.
천골신경 자극기기 시장 역학
천골신경 자극기기 시장은 과활동 방광(OAB), 요실금, 편실금, 전립선암 등의 증례 증가로 제품 수요가 활발하게 성장하고 있습니다. 이러한 질병은 요실금이나 대변실금으로 인한 사람의 일반적인 라이프스타일을 방해할 수 있습니다. 따라서 천골신경 자극기기는 방광과 장 통제 문제를 크게 완화하거나 해결할 수 있습니다. 예를 들어 American Society of Clinical Oncology에 따르면 2022년 미국에서 약 26만 8,490명의 남성이 전립선암으로 진단된 것으로 추정되고 있습니다. 같은 자료에 따르면 2020년 세계 약 141만 4,259명의 남성이 전립선암으로 진단된 것으로 추정되고 있습니다. 전립선 암은 남성에서 가장 흔한 암입니다. 전립선 암은 요폐 및 절박성 요실금과 같은 합병증을 유발하여 사람을 불편하게 만듭니다. 소변 폐쇄 및 절박 요실금은 배뇨의 절박을 감지하고 뇌에 신호를 보내는 천골신경 자극기기의 도움으로 제어할 수 있습니다. 따라서 전립선암의 증례가 증가하고 있기 때문에 시장에서의 천골신경 자극기기 수요가 증가할 가능성이 있습니다.
또한, 배뇨 기능 장애, 요실금, 변실금 등의 질병은 노년 인구에 매우 많습니다. 노화는 근육의 느슨함에 영향을 미치는 심리사회적 요인의 유병률 증가와 관련이 있기 때문에 60세 이상의 사람들은 앞서 언급한 질병을 발병할 위험이 높습니다. 세계보건기구(WHO)(2022)에 따르면 2030년까지 세계 6명 중 1명이 60세 이상이 될 것으로 예측됩니다. 이때 60세 이상의 인구에서 차지하는 비율은 전 세계적으로 2020년 10억명에서 2030년까지 14억명으로 증가할 전망입니다. 게다가 2050년까지 세계의 60세 이상의 인구는 두 배로 늘어나 21억 명 가까이 될 것으로 예상됩니다. 이 통계에 따르면 80세 이상의 인구는 2020년부터 2050년까지 3배로 늘어나 세계에서 4억 2,600만명에 달할 것으로 예측되고 있습니다. 따라서, 증가하는 노년 인구는 요실금과 방광 기능 장애의 위험이 높으며, 그들은 천골신경 자극기기의 사용으로 제어할 수 있습니다. 천골신경 자극기기는 방광을 감지하고 제 시간에 배뇨하도록 뇌에 신호를 보낼 수 있기 때문입니다. 따라서 노년 인구 증가는 천골신경 자극기기 수요를 증가시켜 시장 전체의 성장을 가속시킬 수 있습니다.
따라서, 상기 요인이 2024년부터 2030년까지 예측기간의 천골신경 자극기기 시장의 성장에 기여하고 있습니다.
그러나 이식형 기기 및 관련된 합병증 등은 천골신경 자극기기 시장의 성장을 억제할 수 있습니다.
천골신경 자극기기 시장은 COVID-19 팬데믹 기간에 부정적인 영향을 받았습니다. 팬데믹의 발생은 외래 진찰의 취소나, 긴급성이 없는 병원 진찰의 중지, 외과 수술의 취소로 이어졌습니다. 또한, COVID-19 환자의 치료가 선호되었기 때문에 많은 선택적 수술이 연기되었습니다. 또한 공급망과 원재료 등의 제한으로 인해 장비 제조가 중단되고 시장에서 장비 부족으로 이어지고 있습니다. 그러나 COVID-19의 백신 개발이 경기 회복의 계기가 되고 있습니다. 또, 봉쇄 규제가 완화되어 경제 상황이 정상화됨에 따라 다양한 만성 질환의 치료를 위한 외래 진찰 및 수술 등의 통상의 의료 서비스가 재개되어, 천골신경 자극기기 시장에서 제품 수요가 궤도를 타고 있습니다.
본 보고서에서는 세계의 천골신경 자극기기 시장에 대한 조사 분석, 시장 규모 및 예측, 촉진요인 및 과제, 기업 및 제품프로파일 등의 정보를 제공합니다.
Sacral Nerve Stimulator Devices Market By Product (Implantable Nerve Stimulator And External Nerve Stimulator), By Application (Overactive Bladder, Urinary Or Bowel Urge Incontinence, Chronic Fecal Incontinence, And Others), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of overactive bladder and urge incontinence and the rising technological advancements
The global sacral nerve stimulator devices market was valued at USD 1,064.05 million in 2023, growing at a CAGR of 11.66% during the forecast period from 2024 to 2030. The demand for sacral nerve stimulator devices is primarily being boosted by the increasing figures for urinary retention, urgency frequency, fecal incontinence, and others. Further, the rising adoption of advanced and innovative technologies, the rising demand for minimally invasive treatment approaches, and the increasing product launches and approval among others are thereby contributing to the overall growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.
Sacral Nerve Stimulator Devices Market Dynamics:
The sacral nerve stimulator devices market is witnessing a positive growth in product demand due to the increasing cases of overactive bladder (OAB), urine & fecal incontinence, prostate cancer, and others. These diseases may disturb the normal lifestyle of a person owing to incontinence of urine and stool. Thus, a sacral nerve stimulator can greatly reduce or eliminate bladder and bowel control problems. For instance, according to American Society of Clinical Oncology 2022, it was estimated that in 2022 nearly 268,490 men in the United States were diagnosed with prostate cancer. As per the same source, it was estimated that approximately 1,414,259 men were diagnosed with prostate cancer worldwide in 2020. Prostate cancer is the most common cancer among men. Prostate cancer causes complications like urinary retention and urges incontinence which makes a person uncomfortable. Urinary retention or urge incontinence can be controlled with the help of a sacral nerve stimulator that senses the urgency of urination and send the signal to the brain. Thus, the increasing cases of prostate cancer may increase the demand for sacral nerve stimulators in the market.
Further, voiding dysfunction, urinary incontinence, fecal incontinence, and other diseases are very common in the older population. People more than 60 years are at a higher risk of developing the afore-said diseases as aging is associated with the increasing prevalence of psychosocial factors which affect the loosening of muscles. As per World Health Organization (WHO) 2022, it is predicted that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030, worldwide. Moreover, by 2050, the world's population of people aged 60 years and older will double which is nearly 2.1 billion. The statistics provided by the same source stated that the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, globally. Thus, the increasing geriatric population will be at high risk of urinary incontinence and bladder dysfunction which can be controlled by using a sacral nerve stimulator as sacral nerve stimulator can sense the bladder and send a signal to the brain for urination on time. Thus, the increasing geriatric population may increase the demand for sacral nerve stimulators, thereby propelling the overall market growth.
Therefore, the above-mentioned factors are contributing to the growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.
However, complications related to implantable devices, and others may restrict the sacral nerve stimulator devices market growth.
The sacral nerve stimulator market was negatively impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits, the suspension of non-emergency hospital visits, and the cancellation of surgical procedures. Moreover, many elective surgeries were postponed as treatment of patients suffering from coronavirus infection was on priority. Additionally, the restrictions on the supply chain, raw materials, and other resources halted the manufacturing of devices, leading to a shortage of devices in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, the easing of lockdown restrictions and the return of normalcy in the economic landscape initiated the process of resumption of regular healthcare services such as outpatient visits and surgeries for the treatment of various chronic ailments, thereby bringing the demand for products on track in the sacral nerve stimulator market.
Sacral Nerve Stimulator Devices Market Segment Analysis:
Sacral nerve stimulator devices by Product (Implantable Nerve Stimulator and External Nerve Stimulator), Application (Overactive Bladder (OAB), Urinary or Bowel Urge Incontinence, Chronic Fecal Incontinence, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment of the sacral nerve stimulator devices market, the implantable nerve stimulator category is expected to amass significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment.
For instance, the advantages of implantable sacral nerve stimulators over other products include quicker signal response, less discomfort, minimal invasion, and shorter operating times.
The increasing prevalence of OAB, urine & fecal incontinence, and others may also increase the demand for implantable nerve stimulators.
OAB may affect relationships with friends and family. It can disrupt a person's sleep & sex life and can leave anyone tired and depressed. OAB can lead to urge incontinence, urinating frequent, nocturia, and others. An implantable nerve stimulator can be used to sense quicker urine urgency and can send a signal of the urgency to the brain which may aid in curing the symptoms of urinary incontinence. Thus, the increasing demand for sacral nerve stimulators for the treatment of OAB may lead to an increased demand for implantable nerve stimulator devices.
Furthermore, the increasing awareness regarding sacral nerve stimulators, product launches, and approvals are also a factor for the implantable sacral nerve stimulator market growth. For instance, in 2022, the Axonics F15 device was cleared by the FDA, allowing it to be implanted for upward of 15 years to block the abnormal nerve signals linked to overactive bladder and fecal incontinence.
Therefore, the advantages offered by implantable sacral nerve stimulators are predicted to contribute to the increasing demand for this product thereby driving the growth of the overall sacral nerve stimulator devices market during the forecast period.
North America is expected to dominate the overall Sacral Nerve Stimulator Devices Market:
Among all the regions, North America is estimated to account for the largest share of the sacral nerve stimulator devices market in the year 2023. Factors such as the growing prevalence of urine & fecal incontinence and the increasing cases of OAB are driving the North America sacral nerve stimulator devices market. Further, the increasing geriatric population, the high disposable income, the sophisticated healthcare infrastructure, the regulatory approval for new devices, and the high awareness about the devices also helped the market growth in this region.
Further, people who have urinary retention may have complications, including urinary tract infection (UTI), bladder damage, and kidney damage. According to the Urology Care Foundation 2020, UTIs are very common in the US. In premenopausal women, an annual estimated incidence of UTI is 0.5 - 0.7 per person reported in the US, yearly.
Further, various studies have stated that sacral neuromodulator (SNM) has a positive therapeutic effect on the lower urinary tract and has shown to be an effective treatment for UTI. The urinary tract infection may cause urge incontinence and these patients may require sacral nerve stimulators.
Moreover, the device can also be discontinued at any time without any permanent damage to the nerve. Thus, the increasing number of cases of UTI may increase the number of urinary incontinence cases, ultimately increasing the demand for sacral nerve stimulators, thereby increasing the overall market in the region.
Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in February 2022 Medtronic plc, a global leader in healthcare technology, received approval from the US Food and Drug Administration (FDA) for InterStim X(TM), the next generation of the InterStim(TM) portfolio's recharge-free neurostimulation device, which offers more than 10 years of battery life without the need to recharge, providing patients with more freedom and less maintenance. Thus, such strategic steps help to increase the demand for sacral nerve stimulator devices, thereby driving the North American sacral nerve stimulator devices market forward during the forecast period.
Sacral Nerve Stimulator Devices Market Key Players:
Some of the key market players operating in the sacral nerve stimulator devices market include Medtronic, Axonics, Inc., Boston Scientific Corporation, NeuroPace, Inc., Laborie, Biegler GmbH, Finetech Medical, and others.
Recent Developmental Activities in the Sacral Nerve Stimulator Devices Market:
In February 2023, the US FDA approved Axonics Inc's 4th-generation rechargeable neurostimulator for the treatment of fecal incontinence and overactive bladder.
In August 2021, in the US Finetech-Brindley, a bladder control system was launched as an active implantable medical device and is intended for restoration of bladder function after a complete spinal cord injury. Later the Finetech Brindley bladder control system is named academically as a sacral anterior root stimulator. It is an external, wireless device used to control the implant and its function.
Key Takeaways from the Sacral Nerve Stimulator Devices Market Report Study
Market size analysis for current sacral nerve stimulator devices market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the sacral nerve stimulator devices market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global sacral nerve stimulator devices market.
Various opportunities available for the other competitor in the sacral nerve stimulator devices market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current sacral nerve stimulator devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for sacral nerve stimulator devices market growth in the coming future?
Target Audience who can be benefited from this Sacral Nerve Stimulator Devices Market Report Study
Sacral nerve stimulator devices products providers
Research organizations and consulting companies
Sacral nerve stimulator device s-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in sacral nerve stimulator devices
Various End-users who want to know more about the sacral nerve stimulator devices market and the latest technological developments in the sacral nerve stimulator devices market.
Frequently Asked Questions for the Sacral Nerve Stimulator Devices Market:
The sacral nerve stimulator delivers gentle electrical impulses through a probe (a thin wire) that is placed near the sacral nerve thereby stimulating the bowel and bladder muscles to work normally.
The global sacral nerve stimulator devices market was valued at USD 1,064.05 million in 2023, growing at a CAGR of 11.66% during the forecast period from 2024 to 2030.
The demand for sacral nerve stimulator devices is primarily being heightened by the increasing prevalence of overactive bladder, increasing cases of urge incontinence & fecal incontinence, the rising prevalence of prostate cancer, and others. In addition, the advancement in sacral nerve stimulator devices, and the increasing device launches and approvals among others are thereby contributing to the overall growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.
Some of the key market players operating in the sacral nerve stimulator devices market include Medtronic, Axonics, Inc., Boston Scientific Corporation, NeuroPace, Inc., Laborie, Biegler GmbH, Finetech Medical, and others.
North America is expected to dominate the overall sacral nerve stimulator devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of overactive bladder conditions (OAB) and urge incontinence, the increasing geriatric population, the growing demand for non-invasive treatment, and other factors aid in the growth of the sacral nerve stimulator market in North America. Furthermore, high disposable income, sophisticated healthcare infrastructure, and regulatory approval for new devices also helped the market growth in this region.